ReviewBiomedicines2020

Bi- and Tri-Specific T Cell Engager-Armed Oncolytic Viruses: Next-Generation Cancer Immunotherapy.

Zong Sheng Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.